194 related articles for article (PubMed ID: 8695856)
1. CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells.
Schattner EJ; Mascarenhas J; Bishop J; Yoo DH; Chadburn A; Crow MK; Friedman SM
Blood; 1996 Aug; 88(4):1375-82. PubMed ID: 8695856
[TBL] [Abstract][Full Text] [Related]
2. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.
Schattner EJ; Elkon KB; Yoo DH; Tumang J; Krammer PH; Crow MK; Friedman SM
J Exp Med; 1995 Nov; 182(5):1557-65. PubMed ID: 7595225
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Fas-mediated apoptosis by antigen: implications for lymphomagenesis.
Schattner EJ; Friedman SM; Casali P
Autoimmunity; 2002 Jul; 35(4):283-9. PubMed ID: 12482198
[TBL] [Abstract][Full Text] [Related]
4. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
An S; Yap D; Knox KA
Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
[TBL] [Abstract][Full Text] [Related]
5. Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis.
Gutiérrez MI; Cherney B; Hussain A; Mostowski H; Tosato G; Magrath I; Bhatia K
Cancer Res; 1999 Feb; 59(3):696-703. PubMed ID: 9973220
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr nuclear antigen 1-specific CD4(+) Th1 cells kill Burkitt's lymphoma cells.
Paludan C; Bickham K; Nikiforow S; Tsang ML; Goodman K; Hanekom WA; Fonteneau JF; Stevanović S; Münz C
J Immunol; 2002 Aug; 169(3):1593-603. PubMed ID: 12133989
[TBL] [Abstract][Full Text] [Related]
7. Fas ligation induces apoptosis of CD40-activated human B lymphocytes.
Garrone P; Neidhardt EM; Garcia E; Galibert L; van Kooten C; Banchereau J
J Exp Med; 1995 Nov; 182(5):1265-73. PubMed ID: 7595197
[TBL] [Abstract][Full Text] [Related]
8. Regulation of bcl-xL expression and Fas susceptibility in mouse B cells by CD40 ligation, surface IgM crosslinking and IL-4.
Koizumi T; Wang J; Suzuki Y; Masuda K; Watanabe T
Mol Immunol; 1996 Nov; 33(16):1247-53. PubMed ID: 9129161
[TBL] [Abstract][Full Text] [Related]
9. CD4+ T cells inhibit growth of Epstein-Barr virus-transformed B cells through CD95-CD95 ligand-mediated apoptosis.
Wilson AD; Redchenko I; Williams NA; Morgan AJ
Int Immunol; 1998 Aug; 10(8):1149-57. PubMed ID: 9723701
[TBL] [Abstract][Full Text] [Related]
10. The role of CD40-CD40 ligand interactions in suppression of human B cell responsiveness by CD4+ T cells.
Hirohata S
Cell Immunol; 1997 Nov; 182(1):20-8. PubMed ID: 9427806
[TBL] [Abstract][Full Text] [Related]
11. CD95-mediated apoptosis in Burkitt's lymphoma B-cells is associated with Pim-1 down-regulation.
Matou-Nasri S; Rabhan Z; Al-Baijan H; Al-Eidi H; Yahya WB; Al Abdulrahman A; Almobadel N; Alsubeai M; Al Ghamdi S; Alaskar A; AlBalwi M; Alzahrani M; Alabdulkareem I
Biochim Biophys Acta Mol Basis Dis; 2017 Jan; 1863(1):239-252. PubMed ID: 27641442
[TBL] [Abstract][Full Text] [Related]
12. A dual role for both CD40-ligand and TNF-alpha in controlling human B cell death.
Lens SM; Tesselaar K; den Drijver BF; van Oers MH; van Lier RA
J Immunol; 1996 Jan; 156(2):507-14. PubMed ID: 8543800
[TBL] [Abstract][Full Text] [Related]
13. Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia.
Chu P; Deforce D; Pedersen IM; Kim Y; Kitada S; Reed JC; Kipps TJ
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3854-9. PubMed ID: 11891278
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis induced by TGF-beta 1 in Burkitt's lymphoma cells is caspase 8 dependent but is death receptor independent.
Inman GJ; Allday MJ
J Immunol; 2000 Sep; 165(5):2500-10. PubMed ID: 10946276
[TBL] [Abstract][Full Text] [Related]
15. T cells can induce somatic mutation in B cell receptor-engaged BL2 Burkitt's lymphoma cells independently of CD40-CD40 ligand interactions.
Denépoux S; Fournier N; Péronne C; Banchereau J; Lebecque S
J Immunol; 2000 Feb; 164(3):1306-13. PubMed ID: 10640744
[TBL] [Abstract][Full Text] [Related]
16. On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Greil R; Egle A; Villunger A
Leuk Lymphoma; 1998 Nov; 31(5-6):477-90. PubMed ID: 9922038
[TBL] [Abstract][Full Text] [Related]
17. Essential roles of perforin in antigen-specific cytotoxicity mediated by human CD4+ T lymphocytes: analysis using the combination of hereditary perforin-deficient effector cells and Fas-deficient target cells.
Yanai F; Ishii E; Kojima K; Hasegawa A; Azuma T; Hirose S; Suga N; Mitsudome A; Zaitsu M; Ishida Y; Shirakata Y; Sayama K; Hashimoto K; Yasukawa M
J Immunol; 2003 Feb; 170(4):2205-13. PubMed ID: 12574394
[TBL] [Abstract][Full Text] [Related]
18. Role of CD40 in a T cell-mediated negative regulation of Ig production.
Majlessi L; Bordenave G
J Immunol; 2001 Jan; 166(2):841-7. PubMed ID: 11145658
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis of Burkitt's lymphoma cells induced by specific interaction of surface IgM with a self-antigen: implications for lymphomagenesis in acquired immunodeficiency syndrome.
Roncella S; Cutrona G; Favre A; Ulivi M; Fais F; Signorini A; Grossi CE; Chiorazzi N; Ferrarini M
Blood; 1996 Jul; 88(2):599-608. PubMed ID: 8695808
[TBL] [Abstract][Full Text] [Related]
20. Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor.
Rathmell JC; Townsend SE; Xu JC; Flavell RA; Goodnow CC
Cell; 1996 Oct; 87(2):319-29. PubMed ID: 8861915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]